Grant Details

GRANT OVERVIEW

Grant name and funding organization

Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)

National Institutes of Health (NIH)

Total funding amount and duration

Funding amount is not limited but should reflect the actual needs of the proposed project.

Maximum project period is 5 years.

Primary objective and mission statement

To invite applications proposing research on current topics in Alzheimer's disease (AD) and its related dementias (ADRD).

To encourage biomedical, social, and behavioral research directed toward understanding the aging process and related diseases.

Key stakeholders and beneficiaries

Researchers in the field of Alzheimer's disease and related dementias.

Individuals affected by Alzheimer's disease and their families.

ELIGIBILITY CRITERIA

Organization Requirements

Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local governments, state governments, and tribal governments.

Nonprofits must have 501(c)(3) status or not have such status.

Foreign organizations are eligible to apply.

Geographic Scope

Open to U.S. and non-U.S. entities.

Non-domestic components of U.S. organizations are eligible.

Project Requirements

Research must focus on Alzheimer's disease and related dementias.

Applications must propose scientifically distinct projects.

Financial Requirements

Application budgets are not limited but must reflect actual project needs.

No cost-sharing is required.

Timeline Requirements

Applications are due by November 5, 2027.

The earliest submission date is February 11, 2025.

Previous Funding Considerations

Organizations may submit more than one application, provided each is scientifically distinct.

The NIH will not accept duplicate or overlapping applications under review.

APPLICATION PROCESS

Required documentation and materials

Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.

Applications must comply with all requirements in the Application Guide.

Evaluation criteria and scoring system

Applications will be evaluated based on scientific and technical merit.

Reviewers will consider the importance of the research, rigor and feasibility, and expertise and resources.

Review process and timeline

Applications will undergo peer review by appropriate Scientific Review Groups.

The review process will include a written critique.

Selection criteria and priorities

Scientific and technical merit of the proposed project.

Relevance of the proposed project to program priorities.

SPECIAL CONSIDERATIONS

Unique aspects or requirements

Applications involving human subjects must comply with specific NIH requirements.

Recruitment and retention plans must address barriers to participation.

Potential challenges or limitations

Applicants must ensure compliance with all application instructions to avoid delays or non-acceptance.

Strategic alignment opportunities

Research should align with NIH priorities and address health disparities.

Competitive advantages or disadvantages

Strong applications will demonstrate innovative approaches to research and participant recruitment.

KEY INSIGHTS AND RECOMMENDATIONS

Critical success factors

Adherence to application guidelines and timelines.

Clear articulation of research significance and innovation.

Common pitfalls to avoid

Submitting overlapping applications.

Failing to comply with registration requirements.

Strategic recommendations for applicants

Engage with community partners for recruitment strategies.

Ensure diverse representation in study populations.

Competitive positioning advice

Highlight interdisciplinary approaches and potential for significant impact on AD research.

Grant Details

alzheimer's disease dementia healthcare biomedical research social research behavioral research aging health disparities clinical trials
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
PAR-25-332
Extramural Research Programs in the Neurosciences and Neurological Disorders
EDU NGO ENTERPRISE PUBLIC OTHER
US AF AL DZ AS AD AO AI AQ AG AR AU AT BY BE BG CA CN HR CY CZ DK EG EE FI FR GE DE GI GR HU IS IE IL IT JP LV LI LT LU MK MY MT MX MD NL NZ NO PL PT QA RO SA SC SG SK SI ES SE CH TR UA AE UK VA VG VI
RESEARCH_DEVELOPMENT
False
None
None
None
USD
None
True
True
The grant aims to enhance understanding and treatment of Alzheimer's disease and related dementias, addressing a significant public health crisis.
Research findings that contribute to the understanding of Alzheimer's disease and related dementias.
Nov. 5, 2027, 10 p.m.
To be determined after submission.
Follow the instructions in the How to Apply - Application Guide.
True
Applications will be evaluated based on scientific and technical merit.
Applications should demonstrate innovative approaches to research.
Proposals must be feasible and well-justified.
Research should have the potential for significant impact on the field.
True
True
Grant
Recipients must comply with all NIH policies and guidelines.
Annual progress reports and financial statements are required.
Payments will be made according to NIH policies.
All NIH awards are subject to federal regulations and compliance requirements.
No additional sector-specific requirements noted.